Antibodies targeting IgE Cε2 domain show promise for rapid allergy relief

Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
Healio

Q&A: Allergy test interpretations require caution

Please provide your email address to receive an email when new articles are posted on . Blood tests do not require direct contact with the allergen but take longer than SPTs. SPTs often use allergen ...
Healio

Researchers characterize malignancy risk with IgE deficiencies

Please provide your email address to receive an email when new articles are posted on . 23.5% of patients with an IgE deficiency had a malignancy diagnosis. Nonatopic patients were more likely to have ...
Medscape

Omalizumab: A Recombinant Humanized Anti-IgE Antibody for Allergic Asthma

Purpose: The pharmacology, efficacy, dosage, adverse events, and economics of omalizumab are discussed. Summary: Omalizumab, a recombinant DNA-derived humanized monoclonal antibody, binds to the Cε3 ...
Medscape

Higher Baseline Immunoglobulin E Boosts Omalizumab Outcomes

Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and baseline immunoglobulin E (Ig E) levels are associated with success, based ...
The American Journal of Managed Care

IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD

Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in ...